Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-11

Clinical Trial Update: The Efficacy of Self-Manufactured 40% Dextrose Gel in Asymptomatic Transient Neonatal Hypoglycemia Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of a self-manufactured 40% dextrose gel for asymptomatic transient neonatal hypoglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 40% dextrose gel (dextrose gel)

Snippet

Sponsor: Indonesia University | Conditions: Neonatal Hypoglycemia | Phase 4 | Status: COMPLETED